Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Army
AstraZeneca
Johnson and Johnson
Daiichi Sankyo
Harvard Business School
Chubb
Mallinckrodt
McKesson

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072103

« Back to Dashboard

NDA 072103 describes DESIPRAMINE HYDROCHLORIDE, which is a drug marketed by Actavis Totowa, Amneal Pharms Co, Ani Pharms Inc, Heritage Pharms Inc, Ingenus Pharms Llc, Mountain, Sandoz, and Usl Pharma, and is included in twenty NDAs. It is available from thirteen suppliers. Additional details are available on the DESIPRAMINE HYDROCHLORIDE profile page.

The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.
Summary for 072103
Tradename:DESIPRAMINE HYDROCHLORIDE
Applicant:Sandoz
Ingredient:desipramine hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Pharmacology for NDA: 072103
Medical Subject Heading (MeSH) Categories for 072103
Suppliers and Packaging for NDA: 072103
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 072103 ANDA Sandoz Inc 0781-1975 N 0781-1975-01
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 072103 ANDA Sandoz Inc 0781-1975 N 0781-1975-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Jun 20, 1988TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Cantor Fitzgerald
Mallinckrodt
Julphar
Covington
Farmers Insurance
Moodys
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.